Academic Appointment: Health Sciences Assistant Clinical Professor
Dr. Roach is a Health Sciences Assistant Clinical Professor in the Division of Pediatric Hematology/Oncology and serves as the Director of Pediatric Hematology. Originally from New York State, Dr. Roach moved to California to begin his pediatrics training at UCLA in 2008. He completed both his residency in pediatrics (2011) and his fellowship in hematology and oncology (2014) at UCLA Mattel Children's Hospital. He assumed Directorship of Pediatric Hematology in 2016 and currently oversees the care of children with benign hematologic conditions in the outpatient clinic as well the inpatient consultation service.
Dr. Roach specializes in the research and treatment of benign hematologic disorders including hemophilia, von Willebrand Disease, and other rare bleeding disorders, as well as thrombotic disorders such as deep vein thrombosis, pulmonary embolism, and stroke. He treats patients with bone marrow failure, as well as other disorders of white blood cells, red blood cells, and platelets. He also treats patients with hemoglobinopathies including sickle cell disease and thalassemia. UCLA is referral center for the State newborn screening program for hemoglobinopathies.
In addition to his appointment at UCLA, Dr. Roach provides care for patients with bleeding disorders at the Orthopaedic Institute for Children (OIC) Hemophilia Treatment Center (HTC) in Downtown Los Angeles. This HTC pioneered the concept of providing a comprehensive, multidisciplinary team approach to the management of children and adults with bleeding disorders, and as a result the Center was designated an International Hemophilia Training Center in 1970 – one of the first four in the world — by the World Federation of Hemophilia.
Dr. Roach also serves as the Associate Program Director for the UCLA Pediatric Hematology/Oncology Fellowship Training Program since 2016. His other responsibilities include overseeing the Pediatric Hemapheresis Service, teaching courses in the David Geffen School of Medicine at UCLA, and giving frequent educational lectures to audiences throughout Southern California.
Liu MM, Kohn LA, Roach GD, Sun G, Garcia-Lloret MI, Butte MJ. Treatment of systemic mastocytosis in an infant with midostaurin. J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2929-2931.e1. doi: 10.1016/j.jaip.2019.05.032. Epub 2019 May 31. PMID: 31154031
Friend BD, Roach GD, Kempert PH, Moore TB. Successful Use of Hematopoietic Stem Cell Transplantation for 2 Pediatric Cases of Glanzmann Thrombasthenia and Review of the Literature. J Pediatr Hematol Oncol. 2019 Nov 5. doi: 10.1097/MPH.0000000000001646. [Epub ahead of print] PMID: 31693514
Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2019 Nov 4. pii: S2352-3026(19)30219-4. doi: 10.1016/S2352-3026(19)30219-4. [Epub ahead of print] PMID: 31699660